The primary motivation for MCNB Holding, Corp is to improve life for individuals interested in overall wellness and those who are unable to find safe, affordable, and effective alternative treatments.
Promote physician-backed motivation to close the gap between the
limited treatment for mental health conditions all over the world.
Provide full transparency for clinical trials, medicines with manufacturing, distribution, and storage details for hemp, cannabis, and psychedelics using blockchain tracking technology.
We strive to provide safe and quality products for our consumers.
We intend to positively influence and educate society and expand beyond the threshold of societal understanding of mental health issues.
Chief Executive Officer
Katarina Maloney is a leading biotechnology executive with experience in strategic operations, product development, and supply chain management. She earned dual bachelor’s degrees in European Studies/Political Science and Foreign Language and attended multiple leadership programs through Cornell and Crescom.Chief Strategy Officer
Dr. Michael Pierce has nearly twenty years of experience as a medical provider specializing in neurology, clinical neurochemistry, and functional endocrinology. He holds Bachelor of Science and post-doctorate in Neurology from Carrick Institute of Clinical Neuroscience.Chief Financial Officer
Ali Nasir is considered an expert as an accountant, financial controller, and accounting supervisor. He holds a bachelor’s degree in business economics and accounting from the University of California Santa Barbara.
Partnership provides recruitment of our clinical trial subjects.
Labyrinth Sphere Inc, clinical trial partner is conducting brain wave and biometrics data to understand the effects of psychedelics, hemp and cannabis used as medicine for mental health conditions.
Advarra provides institutional review Board, institutional biosafety committee and global consulting service assistance during trials.
